enGene Holdings, Inc. (ENGN)
7.33
+0.09
(+1.24%)
USD |
NASDAQ |
Apr 07, 16:00
8.01
+0.68
(+9.28%)
After-Hours: 07:05
enGene Holdings Shareholders Equity (Quarterly) : 281.55M for Jan. 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 21.52M |
| Oncolytics Biotech, Inc. | -3.799M |
| Aurinia Pharmaceuticals, Inc. | 581.33M |
| Edesa Biotech, Inc. | 13.95M |
| Lexaria Bioscience Corp. | 4.913M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 337.11M |
| Total Liabilities (Quarterly) | 55.57M |
| Debt to Equity Ratio | 0.1189 |
| Current Ratio | 11.75 |
| Net Debt Paydown Yield | -0.26% |